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Introduction 
The incidence of β - thalassemia in different regions of 
India varies from 3% to 17%, with a mean prevalence of 
4% [1]. Although in the past year’s notable improvements 
in the therapy of thalassemia major have been realized, 
constant and progressive cardiac impairment still leads to 
irreversible cardiac failure, which remains the primary 
cause of death for these patients [2,3]. It is responsible for 
more than half of the deaths. It may take the form of 
cardiomyopathy, pulmonary hypertension, heart failure, 
arrhythmias, pericarditis, and myocarditis [4,5]. 
The cardiac output maintains the blood pressure and the 
total peripheral resistance. These two show a significant 
inverse relationship; that is, the higher the cardiac output, 
the lower is the vascular resistance [6]. 
Sprito et al. reported that blood pressure measured by 
traditional cuff sphygmomanometer at the time of the 
doppler examination was within the normal range but 
slightly and significantly lower in the thalassemia major 
patients compared with control subjects [7]. In contrast, in 
the study done by Tabatabaie and co-workers, a relatively 
high prevalence of elevated blood pressure was reported 
in β-thalassemia major patients [8]. Some studies state 
that, in addition to cardiac complications (such as iron 
deposition in myocytes), this disease probably has a 
protective role against heart diseases by lowering blood 
pressure [9,10]. 
The present study was done to find out the presence of 
impairment of blood pressure in beta-thalassemia major 
patients without any clinical evidence of heart disease. 
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Materials and Methods 
The present study was a cross sectional analytical type of 
study conducted in the Department of Physiology and 
Department of Paediatric Medicine, Grant Government 
Medical College, Mumbai and in the Thalassemia unit of 
St. George Hospital, Mumbai. Before commencement of 
the project, approval was taken from the Institutional 
Ethical Committee. Written informed consent was taken 
before the clinical examination of the subject. 
The study design involved 200 individuals who were 
divided into two groups of 100 normal subjects (control 
group) and 100 patients of beta thalassemia major (study 
group) between the age group of 8 to 20 years involving 
both, males and females receiving regular blood 
transfusions at least since 5 years. Patients with 
concomitant sickle cell anaemia or with associated 
congenital or acquired heart disease, diabetes mellitus, 
thyroid disorders or any other endocrine disorder or on 
long term medications for any other chronic disease were 
excluded from the study. Written informed consent was 
taken before the clinical examination of the subject. 
The subjects were asked to refrain from ingesting any 
beverages containing caffeine and alcohol for at least 12 
hours prior to the study. They were asked to report 
between 10 a.m. to 12 p.m. in the lab after an adequate 
night’s sleep followed by light breakfast. A detailed 
recording of medical, personal and family history and 
clinical examination of the subjects was carried out. Body 
weight (in kg) and height (in cm) were taken and BMI 
was calculated. The Arterial blood pressure of each 
subject was recorded in the right arm in sitting position 
using mercury sphygmomanometer. The subject was 
seated quietly in a chair with back support, with both feet 
flat on the floor. The patient was instructed to relax as 
much as possible and to not talk during the measurement 
procedure [11].  
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Abstract 
Introduction: β-thalassemia major patients need to have repeated blood transfusions throughout their life for survival, 
which leads to various complications. Heart disease is the most critical complication and the primary determinant of 
survival in these patients. Our study shows a comparison of blood pressure between these patients and that of healthy 
subjects. Methods: The present study was a cross-sectional type of study and consisted of 100 healthy subjects (control 
group) and 100 patients of beta-thalassemia major (study group). Blood pressure was recorded in both the groups using a 
mercury sphygmomanometer and statistical analysis of the observations was done using the Z test. Results: There was no 
statistically significant difference in the Systolic blood pressure (SBP) of the study group as compared to the control 
group, whereas there was statistically significant difference (p-value <0.0001) in the Diastolic blood pressure (DBP) of 
the study group. Conclusion: There was an overall reduction in the blood pressure of the study group as compared to the 
control group, but the difference in SBP was statistically not significant, whereas that of DBP was statistically significant.  
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Statistical analysis of the observations was carried out 
using Z test. Statistical significance was tested at 5% & 
expressed in terms of ‘p’ value with p˂0.05 as statistically 
significant. 
Results   
Table 1: General growth parameters, Comparison of 
Systolic and Diastolic blood pressure of subjects  
Statistical analysis using ‘Z’ test, * Significant  
(BMI – Body mass index, SBP – Systolic blood pressure, 
DBP – Diastolic blood pressure) 
Comparison of general growth parameters between study 
group and control group is as shown in table 1.  The mean 
Body mass index (BMI) was 17.01±3.21 and 18.05±3.74 
kg/m² in the study and control group respectively. As 
shown in table there was no statistically significant 
difference (p˃0.05) in systolic blood pressure of study 
group as compared to control group. There was a 
difference in diastolic blood pressure of study group and 
control group which was statistically significant (p value 
<0.0001). 
Discussion 
The systolic blood pressure of study group and control 
group was 101.4±7.16 and 102.8±8.8 mmHg respectively 
and the difference was statistically not significant. 
However the diastolic blood pressure of study group and 
control group was 57.72±9.54 and 69.64±6.23 mmHg 
respectively and the difference was statistically 
significant. This is in accordance with study done by 
Veglio et al who observed that in thalassemia major 
patients, the overall amplitude of systolic BP and diastolic 
BP was significantly lower than in controls [12].  
This may be because the chronic anemics of thalassemia 
have a high cardiac output state caused by a low systemic 
vascular resistance. This has been hypothesised to result 
from vasodilation secondary to reduced inhibition of 
endothelium derived relaxing factor by low circulating 
haemoglobin [13]. Nitya Nand et al has shown that 
patients with severe chronic anemia had significantly low 
blood pressure as compared to control subjects [14].  
Aniruddha et al shown similar findings in iron deficiency 
anemia patients [15]. According to them this fall in blood 
pressure may be the result of decreased peripheral 
resistance due to anemia in iron deficiency anemia.  
 In β-thalassemia major, endothelial dysfunction is also 
one of the fundamental pathophysiologic mechanisms that 
play a role in progression of cardiovascular involvements. 
Many studies have showed there is an endothelial 
dysfunction in different vascular beds in these patients. 
Gullu found that diastolic peak flow velocity of the left 
anterior descending coronary artery was significantly 
higher in the β-thalassemia major group at baseline, 
however, coronary flow reserve (reflecting of 
microvascular function), is impaired and is significantly 
lower than control group [16]. Endothelial dysfunction 
may be because of alteration of nitric oxide synthesis and 
consumption, inflammation or may be due to 
hypercoagulable state [17,18].  
In contrast to above studies, study done by Tabatabaie 
and co-workers reported a relatively high prevalence of 
elevated blood pressure (16.7%) and no dipper statues 
(56.7%) in β-thalassemia major patients [8]. These 
findings may be consequent to arterial stiffness, 
endothelial dysfunction, and autonomic neural 
dysfunction. Also, study done by Kazemi Jahromi M et al 
shown that there was no significant difference in blood 
pressure between thalassemia major patients and normal 
subjects [19]. 
Conclusion 
There was an overall reduction in blood pressure in 
thalassemia major patients as compared to controls group 
but the difference in SBP was statistically not significant 
whereas that of DBP was statistically significant. This 
may be because of chronic anemia resulting into 
peripheral vasodilation secondary to tissue hypoxia 
leading to lower vascular resistance or may be due to 
endothelial dysfunction. Thus, there was impairment of 
blood pressure in beta thalassemia major patients in a pre-
clinical phase of heart disease. 
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